These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 15659291)

  • 1. A tachykinin NK1 receptor antagonist attenuates the 4 beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat.
    Tsuchiya M; Sakakibara A; Yamamoto M
    Eur J Pharmacol; 2005 Jan; 507(1-3):29-34. PubMed ID: 15659291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal ventral root after-discharges as a pain index: involvement of NK-1 and NMDA receptors.
    Yamamoto S; Honda M; Tanabe M; Ono H
    Brain Res; 2006 Apr; 1082(1):115-23. PubMed ID: 16507302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.
    Ren K; Iadarola MJ; Dubner R
    Br J Pharmacol; 1996 Jan; 117(1):196-202. PubMed ID: 8825363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol.
    Steensland P; Simms JA; Nielsen CK; Holgate J; Bito-Onon JJ; Bartlett SE
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice.
    Ferreira J; Trichês KM; Medeiros R; Calixto JB
    Pain; 2005 Sep; 117(1-2):171-81. PubMed ID: 16099101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites.
    Reed-Hagen AE; Tsuchiya M; Shimada K; Wentland JA; Obach RS
    Biopharm Drug Dispos; 1999 Dec; 20(9):429-39. PubMed ID: 10951432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the antinociceptive and anti-inflammatory effects of bis selenide in mice.
    Jesse CR; Savegnago L; Nogueira CW
    J Pharm Pharmacol; 2009 May; 61(5):623-30. PubMed ID: 19406001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
    Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
    Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
    Prakash C; O'Donnell J; Khojasteh-Bakht SC
    Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain.
    Pitcher GM; Henry JL
    Exp Neurol; 2004 Apr; 186(2):173-97. PubMed ID: 15026255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
    Parenti C; Aricò G; Ronsisvalle G; Scoto GM
    Peptides; 2012 Apr; 34(2):412-8. PubMed ID: 22306475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
    Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
    Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eziopitant. Pfizer.
    Evangelista S
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1441-3. PubMed ID: 11890362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats.
    Ma QP; Woolf CJ
    Eur J Pharmacol; 1997 Mar; 322(2-3):165-71. PubMed ID: 9098683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
    Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
    Obach RS
    Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
    Gavva NR; Tamir R; Qu Y; Klionsky L; Zhang TJ; Immke D; Wang J; Zhu D; Vanderah TW; Porreca F; Doherty EM; Norman MH; Wild KD; Bannon AW; Louis JC; Treanor JJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):474-84. PubMed ID: 15615864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the involvement of metabotropic glutamatergic, neurokinin 1 receptor pathways and protein kinase C in the antinociceptive effect of dipyrone in mice.
    Siebel JS; Beirith A; Calixto JB
    Brain Res; 2004 Apr; 1003(1-2):61-7. PubMed ID: 15019564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.